Página 2 - Melhores Metaplasia gástrica médicos - TOP-57 médicos

O Dr. Yildiz possui ampla experiência de pesquisa em tumores neuroendócrinos gastroenteropancreáticos, com publicações na Medical Oncology e em outras revistas de renome.

• Especializar-se em tumores neuroendócrinos e condições relacionadas
• Publicar múltiplos estudos sobre síntese de esteroides e diabetes
• Pesquisar casos raros, como o pênfigo paraneoplásico
• Trabalhar no Hospital Universitário Medipol Mega

Um oncologista austríaco de renome, especializado em terapia sistémica e personalizada. O Prof. Köstler traz mais de 20 anos de experiência em cuidados oncológicos de excelência para a Wiener Privatklinik.

• Autoridade internacional em tratamentos direcionados e imunoterapia
• Foco em cancros da mama e ginecológicos
• Consultor sénior e ex-vice-diretor de oncologia na Universidade Médica de Viena
• Professor associado dedicado à investigação de biomarcadores e biologia tumoral

O Professor Sebastian Keil é especialista em técnicas avançadas de radiologia diagnóstica e intervencionista, com vasta experiência em imagiologia de metaplasia gástrica.

• Graduar-se com honras pela Universidade Julius-Maximilian de Würzburg
• Aprofundar a experiência no Hospital Universitário de Aachen sob a orientação de professores de renome
• Nomeação como Médico Chefe de Radiologia Diagnóstica e Intervencionista no Hospital Académico de Solingen
• Especializar-se em exames de RM e TC para todas as regiões do corpo
• Oferecer uma gama completa de serviços de radiologia intervencionista

A Dra. Viola Fox lidera a Clínica de Hematologia, Oncologia e Cuidados Paliativos no BKZ Solingen, especializando-se em tratamentos avançados contra o cancro.

• Especializar-se em hematologia, oncologia e imunologia desde 2011
• Ser qualificada em genética, aprimorando abordagens de tratamento personalizado
• Atuar na investigação em biologia molecular para terapias oncológicas inovadoras
• Ser membro de sociedades de oncologia alemãs e americanas

O Dr. Alemdar é especialista em metaplasia gástrica, com uma sólida formação académica na Universidade de Akdeniz.

• Certificado em Medicina Interna e Oncologia Médica
• Anos de experiência hospitalar, inclusive no Hospital Universitário de Akdeniz
• Especialista na gestão de condições gastrointestinais complexas
• Ser ativo em investigação e formação em hospitais universitários

Como Chefe do Centro de Câncer Gastrointestinal, o Dr. Hubert lidera uma unidade especializada em cancros digestivos complexos.

• 33 anos de experiência clínica em oncologia e radioterapia
• Dupla certificação de especialista em oncologia e radioterapia
• Médico sénior no Hospital Universitário Hadassah
• Membro ativo do Comité de Israel para o Cancro Gastrointestinal
• Formação inclui licenciatura em medicina e em psicologia

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

O professor Gul Alco traz mais de 25 anos de experiência especializada em radioncologia em instituições líderes na Turquia, como o Hospital Distrital Medipol Acibadem.

• Formado na Universidade de Istambul – uma das melhores faculdades de medicina da Turquia
• Atual professor de radioncologia na Universidade Istambul Medipol
• Experiência como professor associado na Universidade Demiroglu Bilim
• Especializado em terapias de radiação gastrointestinal

Especializada em viroterapia – um dos mais recentes campos da imunologia – a Dra. Jaunalksne traz abordagens inovadoras na Clínica Pallas.

• Mais de 30 anos de experiência em imunologia
• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Graduada pelo Instituto Médico de Riga com internato em Medicina Interna

O Dr. Al é especialista em cirurgia laparoscópica para doenças gástricas, formado nas faculdades Çapa e Cerrahpaşa da Universidade de Istambul.

• Certificado pelo conselho com mais de 30 anos de experiência cirúrgica
• Formação avançada em cirurgia laparoscópica bariátrica e oncológica
• Especialização em técnicas de cirurgia laparoscópica antirrefluxo
• Realizar procedimentos minimamente invasivos para uma recuperação mais rápida

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Especializado em cancro gástrico e condições relacionadas, com vasta experiência cirúrgica nos Hospitais Büyük Anadolu.

• Experiente em cirurgias de pâncreas e vias biliares
• Realizar cirurgias bariátricas e metabólicas
• Especialista em cirurgias oncológicas e mamárias